Categories: News

1933 Industries Extends Expiry Date of Warrants

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

VANCOUVER, BC / ACCESSWIRE / June 5, 2024 / 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, announces that it reached an agreement to amend the expiry date of its outstanding 3,700,000 warrants (the “Warrants”), from June 13, 2024, to November 9, 2025. The Warrants were originally issued on November 9, 2020, and have an exercise price of $0.075. The exercise price and all other terms of the Warrants will remain in full force and effect.

About 1933 Industries Inc.

1933 Industries is a Nevada-based company, focusing on the cultivation and manufacturing of a large portfolio of cannabis consumer-packaged goods in a variety of formats for both the wholesale and retail markets. Its product offerings through its in-house brands include: wholesale flower, pre-rolls, and extracted products under the AMA and Level X brands for the Nevada market; and Canna Hemp™, a national cannabidiol (CBD) brand of wellness products that includes tinctures, gummies, topicals and sports recovery products. The Company owns 91% of Alternative Medicine Association, LC (AMA) and 100% of Infused MFG LLC (Infused). For more information, please visit www.1933industries.com

For further information please contact:
Alexia Helgason, VP, IR, Marketing, Media
604-728-4407
alexia@1933industries.com

Paul Rosen, CEO
paul@1933industries.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: 1933 Industries Inc.

View the original press release on accesswire.com

Staff

Recent Posts

Develop Health Raises $14.3M to Automate Prior Authorization and Medication Access Using GenAI

The GenAI-powered platform automates benefit verification, prior authorization, and payer follow-up to reduce treatment delays…

3 hours ago

Nym Rated a Top Performer by KLAS in First Report Dedicated to Autonomous Medical Coding

Report underscores autonomous coding’s rapid adoption and Nym’s role in delivering efficiency and scalability to…

3 hours ago

Pathway to Cures Portfolio Company Spark Biomedical Receives Wellcome Leap Award for Advancements in Women’s Health: Heavy Menstrual Bleeding

NEW YORK--(BUSINESS WIRE)--#NBDF--Pathway to Cures (P2C) congratulates Dr. Navid Khodaparast, PhD, co-founder and CSO of…

3 hours ago

Barry University School of Podiatric Medicine Ignites Innovation with ModMed® Podiatry

BOCA RATON, Fla.--(BUSINESS WIRE)--ModMed® announced today that Barry University School of Podiatric Medicine has chosen…

3 hours ago

eClinicalWorks and Sunoh.ai Boost Patient Care and Cut Documentation Time by Over an Hour Daily at South Lake Pediatrics

The 36-provider practice streamlines documentation and enhances patient care with Sunoh.ai integration.WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the…

3 hours ago

Global Healthcare Innovator Qure.ai Expands Executive Team With Eminent Lung Health Appointment to Accelerate Clinical Strategy

Dr. Javier J. Zulueta enters boardroom as Chief Medical Officer, Pulmonology, with potential of changing…

3 hours ago